Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TYK-00540 in advanced solid tumors
NCT06950086Phase 2Recruiting
- Sponsor
- TYK Medicines
- Start
- Jan 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TYK-00540 in solid tumor (advanced stage), breast cancer, ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by TYK Medicines. Started Jan 2024; status: recruiting.
02
Drugs
TYK-00540
03
Conditions
solid tumor (advanced stage)breast cancerovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT06950086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06950086.